FATE OF DRUGS IN ORGANISM

[61] GILLETTE JR, 1962, 1 P INT PHARM M STOC, V6, P13

[62] GILLETTE JR, 1964, 1963 P INT PHARM M

[63] HECHT G, 1961, ARZNEIMITTEL-FORSCH, V11, P695

[64] PURINE AND PYRIMIDINE ANTIMETABOLITES IN CANCER CHEMOTHERAPY [J]. ADVANCES IN PHARMACOLOGY, 1963, 2 : 297 - 343

[65] HERKEN H., 1963, ARCH EXPTL PATHOL U PHARMAKOL, V244, P442

[66] HERMANN J, 1964, ARCH EXP PATHOL PH, V247, P19

[67] HERMANN J, 1964, ARCH EXP PATHOL PH, V247, P35

[68] HERRMANN J, 1964, ARCH EXP PATHOL PH, V248, P370

[69] HERRMANN J, 1964, ARCH EXP PATHOL PH, V247, P1

[70] HERRMANN J, 1962, ARCH EXP PATHOL PH, V243, P333

[61] GILLETTE JR, 1962, 1 P INT PHARM M STOC, V6, P13

[62] GILLETTE JR, 1964, 1963 P INT PHARM M

[63] HECHT G, 1961, ARZNEIMITTEL-FORSCH, V11, P695

[64] PURINE AND PYRIMIDINE ANTIMETABOLITES IN CANCER CHEMOTHERAPY [J]. ADVANCES IN PHARMACOLOGY, 1963, 2 : 297 - 343

[65] HERKEN H., 1963, ARCH EXPTL PATHOL U PHARMAKOL, V244, P442

[66] HERMANN J, 1964, ARCH EXP PATHOL PH, V247, P19

[67] HERMANN J, 1964, ARCH EXP PATHOL PH, V247, P35

[68] HERRMANN J, 1964, ARCH EXP PATHOL PH, V248, P370

[69] HERRMANN J, 1964, ARCH EXP PATHOL PH, V247, P1

[70] HERRMANN J, 1962, ARCH EXP PATHOL PH, V243, P333